Complement activating and opsonic capacity of monoclonal antibodies raised againstEscherichia coli O111 and its rough mutant J5 R. W. VreedeJ. LeuveninkJ. Verhoef Articles Pages: 141 - 147
Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria J. de Jongh-LeuveninkA. S. BouterJ. Verhoef Articles Pages: 148 - 151
Faecal carriage of group B streptococci K. M. -S. PerssonB. BjerreA. Forsgren Articles Pages: 156 - 159
Rapid identification ofClostridium difficile by determination of leucine arylamidase activity A. KudhairM. DelméeG. Wauters Notes Pages: 160 - 161
Evaluation of primary selective media and enrichment methods forCampylobacter species isolation F. T. H. ChanA. M. R. Mackenzie Notes Pages: 162 - 164
Episiotomy wound infection due toGardnerella vaginalis M. N. H. ChowdhuryS. K. Desilva Notes Pages: 164 - 165
Antimicrobial susceptibility of group B streptococci K. M. -S. PerssonA. Forsgren Notes Pages: 165 - 167
Stevens-Johnson syndrome with isolation ofMycoplasma pneumoniae from skin lesions M. A. MeseguerL. de RafaelM. L. Vidal Notes Pages: 167 - 168
Unusual clinical features of an epidemic of listeriosis associated with a particular phage type R. MalinverniM. P. GlauserJ. Rocourt Notes Pages: 169 - 171
Epstein-Barr virus-specific immunoglobulin A in patients with infectious mononucleosis, an age-dependent factor H. OberenderE. StraubeI. Morfiadakis Notes Pages: 173 - 174
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration K. BornerG. HöffkenD. Reinitz Articles Pages: 179 - 186
Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses T. BerganS. B. ThorsteinssonS. Johnsen Articles Pages: 187 - 192
Single and multiple dose pharmacokinetics of ciprofloxacin U. UllmannW. GiebelP. Koeppe Articles Pages: 193 - 196
Penetration of ciprofloxacin into bronchial secretions E. Bergogne-BérézinG. BerthelotP. Reynaud Articles Pages: 197 - 200
Effect of oral ciprofloxacin on the faecal flora of healthy volunteers H. A. HoltD. A. LewisD. S. Reeves Articles Pages: 201 - 205
Penetration of ciprofloxacin into cerebrospinal fluid G. ValainisD. ThomasG. Pankey Notes Pages: 206 - 207
Penetration of ciprofloxacin into female pelvic tissues S. SegevE. RubinsteinM. Dolitsky Notes Pages: 207 - 209
Intraperitoneal penetration of ciprofloxacin M. R. LockleyR. WaldronI. A. Donovan Notes Pages: 209 - 210
Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection M. GrabeA. ForsgrenT. Björk Notes Pages: 211 - 212
Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue F. D. DaschnerM. WestenfelderA. Dalhoff Notes Pages: 212 - 213
Clinical experience with ciprofloxacin in the USA G. ArcieriR. AugustB. O'Brien Articles Pages: 220 - 225
Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis B. I. DaviesF. P. V. MaesenC. Baur Articles Pages: 226 - 231
Evaluation of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections H. GiamarellouN. GalanakisG. K. Daikos Articles Pages: 232 - 235
Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections F. FollathM. BindschedlerH. Reber Articles Pages: 236 - 240
Ciprofloxacin in the treatment of acute bacterial diarrhea: A double blind study H. PichlerG. DiridlD. Wolf Articles Pages: 241 - 243
Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin M. J. A. M. Tegelberg-StassenJ. C. S. van der HoekE. Stolz Articles Pages: 244 - 246
Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria J. GuibertD. DestréeJ. Acar Notes Pages: 247 - 248
Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria S. MehtarY. DrabuP. Blakemore Notes Pages: 248 - 251
Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis H. Van PoppelM. WeggeV. Chysky Notes Pages: 251 - 253
Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection H. J. Peters Notes Pages: 253 - 255
Ciprofloxacin in the treatment of urinary tract infections caused byPseudomonas aeruginosa and multiresistant bacteria S. SaavedraC. H. Ramírez-RondaM. Nevárez Notes Pages: 255 - 257
Clinical evaluation of treatment with ciprofloxacin R. FinchM. WhitbyR. Pilkington Notes Pages: 257 - 259
Treatment of chronic salmonella carriers with ciprofloxacin G. DiridlH. PichlerD. Wolf Notes Pages: 260 - 261
